BioLife Solutions, Inc.

NasdaqCM:BLFS Stock Report

Market Cap: US$1.4b

BioLife Solutions Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:BLFS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
09 Mar 26SellUS$1,962,998Karen FosterIndividual97,423US$20.15
15 Dec 25SellUS$49,200Amy DuRossIndividual2,000US$24.60
15 Dec 25SellUS$17,440Sarah AebersoldIndividual713US$24.46
04 Dec 25SellUS$771,600Troy WichtermanIndividual30,000US$25.72
26 Nov 25SellUS$108,000Amy DuRossIndividual4,000US$27.00
21 Nov 25SellUS$148,545Amy DuRossIndividual6,000US$26.00
13 Nov 25SellUS$2,580,422Roderick de GreefIndividual100,000US$26.15
15 Oct 25SellUS$21,410,325Casdin Capital, LLCCompany750,000US$28.55
25 Aug 25SellUS$255,300Todd BerardIndividual10,000US$25.53
15 Aug 25SellUS$12,200,000Casdin Capital, LLCCompany500,000US$24.40
11 Aug 25SellUS$11,300,000Casdin Capital, LLCCompany500,000US$22.60

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of BLFS?
Owner TypeNumber of SharesOwnership Percentage
State or Government7,8230.0153%
Individual Insiders1,412,3062.76%
VC/PE Firms4,757,1659.28%
Institutions45,058,98687.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 78.64% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.4%
T. Rowe Price Group, Inc.
6,546,641US$184.9m25.6%0.01%
12.5%
BlackRock, Inc.
6,101,765US$172.3m3.22%no data
9.74%
Casdin Capital, LLC
4,757,165US$134.3m-20.1%6.91%
4.66%
Invesco Ltd.
2,276,676US$64.3m-41%0.01%
3.93%
Vanguard Capital Management, LLC
1,917,708US$54.2m0%no data
3.23%
State Street Global Advisors, Inc.
1,577,076US$44.5m4.75%no data
3.01%
FMR LLC
1,469,622US$41.5m-5.04%no data
2.45%
Massachusetts Financial Services Company
1,197,257US$33.8m19.2%0.01%
2.21%
Fred Alger Management, LLC
1,079,935US$30.5m-0.36%0.1%
2.12%
Dimensional Fund Advisors LP
1,035,757US$29.2m1.03%no data
1.99%
Geode Capital Management, LLC
971,927US$27.4m1.97%no data
1.84%
Columbia Management Investment Advisers, LLC
901,138US$25.4m-0.35%no data
1.77%
Vanguard Portfolio Management, LLC
865,038US$24.4m0%no data
1.55%
Palisade Capital Management, LP
758,659US$21.4m-6.46%0.65%
1.52%
Rockefeller & Co. LLC
741,352US$20.9m5.03%0.03%
1.51%
Nationwide Fund Advisors
739,803US$20.9m-7.93%0.09%
1.48%
Granahan Investment Management, LLC
722,057US$20.4m49.7%0.71%
1.38%
RBC Global Asset Management Inc.
676,144US$19.1m6.19%0.01%
1.38%
Stephens Investment Management Group, LLC
673,129US$19.0m10.9%0.22%
1.3%
Cramer Rosenthal McGlynn LLC
632,812US$17.9m0%1.05%
1.2%
Managed Account Advisors LLC
588,711US$16.6m124%no data
1.2%
Royce & Associates, LP
584,011US$16.5m40%0.12%
1.17%
Mutual of America Capital Management LLC
572,729US$16.2m-0.48%0.13%
1.1%
Gagnon Securities, LLC
536,512US$15.2m0.4%2.88%
1.02%
Voya Investment Management LLC
496,937US$14.0m0%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/01 21:45
End of Day Share Price 2026/07/01 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioLife Solutions, Inc. is covered by 18 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert WassermanBenchmark Company
Paul KnightBrean Capital Historical (Janney Montgomery)
George ZavoicoB. Riley Securities, Inc.